• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report.多巴胺调节障碍综合征的识别与挑战:一例报告
Cureus. 2025 Jun 22;17(6):e86547. doi: 10.7759/cureus.86547. eCollection 2025 Jun.
2
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.左旋多巴/卡比多巴肠凝胶对晚期帕金森病患者“关”期的长期影响:一项系统评价
Adv Ther. 2021 Jun;38(6):2854-2890. doi: 10.1007/s12325-021-01747-1. Epub 2021 May 20.
3
Symptom improvement in a South Asian patient with Parkinson's disease treated with immediate- and extended-release carbidopa-levodopa: a case report.一名接受速释和缓释卡比多巴-左旋多巴治疗的南亚帕金森病患者的症状改善:病例报告
J Med Case Rep. 2025 Jul 7;19(1):321. doi: 10.1186/s13256-025-05385-x.
4
Sublingual Crushed Levodopa for Parkinson's Disease Management of a Lewy Body Dementia Patient With Dysphagia: A Case Report.舌下含服碾碎的左旋多巴用于管理一名患有吞咽困难的路易体痴呆帕金森病患者:病例报告
Cureus. 2025 May 29;17(5):e85064. doi: 10.7759/cureus.85064. eCollection 2025 May.
5
Severe Relapsing Hailey-Hailey Disease Displaying a Durable Complete Response to Hydroxyurea.严重复发性黑利-黑利病对羟基脲呈现持久完全缓解
Acta Dermatovenerol Croat. 2024 Nov;32(3):168-169.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
-Related Tetrahydrobiopterin Deficiency (PTPSD)- 相关四氢生物蝶呤缺乏症(PTPSD)
8
Ropinirole for levodopa-induced complications in Parkinson's disease.罗匹尼罗用于治疗帕金森病中左旋多巴引起的并发症。
Cochrane Database Syst Rev. 2001(1):CD001516. doi: 10.1002/14651858.CD001516.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Bromocriptine versus levodopa in early Parkinson's disease.早期帕金森病中溴隐亭与左旋多巴的对比
Cochrane Database Syst Rev. 2000(3):CD002258. doi: 10.1002/14651858.CD002258.

本文引用的文献

1
New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.用于治疗帕金森病冲动-强迫行为的新药理学和神经调节方法。
Neurol Sci. 2021 Jul;42(7):2673-2682. doi: 10.1007/s10072-021-05237-8. Epub 2021 Apr 14.
2
Dopamine dysregulation syndrome in non-Parkinson's disease patients: a systematic review.非帕金森病患者的多巴胺调节障碍综合征:一项系统评价
Australas Psychiatry. 2019 Oct;27(5):456-461. doi: 10.1177/1039856219839476. Epub 2019 Apr 29.
3
Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases.帕金森病中多巴胺失调综合征:已发表病例的系统评价。
J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1060-1064. doi: 10.1136/jnnp-2017-315985. Epub 2017 Oct 10.
4
Successful treatment of dopamine dysregulation syndrome with valproic acid.丙戊酸成功治疗多巴胺失调综合征。
J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):E3. doi: 10.1176/appi.neuropsych.13060126.
5
Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome.帕金森病中多巴胺失调综合征:从临床和神经心理学特征到管理和长期预后。
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):311-8. doi: 10.1136/jnnp-2012-303988. Epub 2013 Apr 16.
6
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.丙戊酸钠治疗帕金森病多巴胺失调综合征(DDS)。
J Neurol. 2013 Feb;260(2):521-7. doi: 10.1007/s00415-012-6669-1. Epub 2012 Sep 25.
7
Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward.帕金森病多巴胺能药物治疗的强迫性使用:奖励和反奖励。
Mov Disord. 2010 May 15;25(7):867-76. doi: 10.1002/mds.22898.
8
Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.多巴胺调节障碍综合征:其流行病学、机制及管理概述
CNS Drugs. 2009;23(2):157-70. doi: 10.2165/00023210-200923020-00005.
9
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?帕金森病中多巴胺替代疗法的强迫性使用:奖赏系统出问题了吗?
Lancet Neurol. 2003 Oct;2(10):595-604. doi: 10.1016/s1474-4422(03)00529-5.
10
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.帕金森病患者接受多巴胺替代疗法时的享乐性稳态失调。
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423-8. doi: 10.1136/jnnp.68.4.423.

多巴胺调节障碍综合征的识别与挑战:一例报告

The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report.

作者信息

Sulaiman Andrew, Leppla Idris

机构信息

Psychiatry, Johns Hopkins University, Baltimore, USA.

出版信息

Cureus. 2025 Jun 22;17(6):e86547. doi: 10.7759/cureus.86547. eCollection 2025 Jun.

DOI:10.7759/cureus.86547
PMID:40698232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12282977/
Abstract

A 48-year-old man with a history of opioid use disorder (unmanaged) and presumed Parkinson's disease presented to the emergency department secondary to worsening of his Parkinson's tremors/ambulatory dysfunction. He expressed that he was taking up to 20 doses of his carbidopa/levodopa (25mg-250mg pills for a total of >5g levodopa every day). The patient was admitted for the management of Parkinson's tremors and substance abuse. He was administered carbidopa/levodopa (25mg-250mg) every eight hours. Psychiatry was consulted due to marked functional fluctuations in his presentation and found that he demonstrated positive choreiform movements of the head/neck and upper extremity after taking the carbidopa. The patient's presentation prompted a suspicion of dopamine dysregulation syndrome (DDS). Supporting evidence included that the patient was insistent that the current regimen of carbidopa/levodopa wasn't managing symptoms, and even when the frequency was increased to every six hours, the patient expressed that his symptoms were still present and problematic. The patient stated that if the carbidopa/levodopa dosage wasn't further increased, he would leave the hospital. He ended up leaving against medical advice and was later ultimately re-admitted with the goal of transitioning to a rehabilitation facility for the treatment optimization of his substance use disorder and Parkinson's disease. This case demonstrates the challenges and presentation of DDS. DDS is a disorder marked by compulsive overuse of dopaminergic medication, which frequently occurs in individuals with Parkinson's disease. Additionally, this case reviews diagnostic criteria and moreover summarizes literature supporting methods of clinical management.

摘要

一名48岁男性,有阿片类药物使用障碍病史(未得到控制),并被推测患有帕金森病,因帕金森震颤/行走功能障碍恶化而就诊于急诊科。他表示自己每天服用多达20剂卡比多巴/左旋多巴(25毫克 - 250毫克片剂,左旋多巴总量>5克)。患者因帕金森震颤和药物滥用问题入院治疗。每八小时给他服用一次卡比多巴/左旋多巴(25毫克 - 250毫克)。由于其临床表现存在明显的功能波动,于是咨询了精神科,结果发现他在服用卡比多巴后出现了头部/颈部和上肢的阳性舞蹈样动作。患者的表现引发了对多巴胺调节障碍综合征(DDS)的怀疑。支持证据包括患者坚持认为目前的卡比多巴/左旋多巴治疗方案无法控制症状,即使服药频率增加到每六小时一次,患者仍表示症状依然存在且很严重。患者称如果不进一步增加卡比多巴/左旋多巴的剂量,他就会出院。他最终不听从医嘱自行出院,后来又再次入院,目的是转至康复机构,以优化其药物使用障碍和帕金森病的治疗。该病例展示了DDS的挑战和临床表现。DDS是一种以多巴胺能药物强迫性过度使用为特征的疾病,常见于帕金森病患者。此外,该病例回顾了诊断标准,并总结了支持临床管理方法的文献。